Parray et al. [15] found significantly higher expression of MAP2K6 in esophageal, gastric, and colon cancers than in controls using protein blotting and immunofluorescence assays, and overexpression of MAP2K6 suggests a role in human cancers. Here, MAP2K6 is linked to malignant colon neoplasm.